NCT00050648 - To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 1997

Primary Completion Date

September 30, 2004

Study Completion Date

April 30, 2008

Conditions

Psoriasis

Interventions

DRUG

Daclizumab

1mg/kg medication every other week on the odd week (week 1-13).

DRUG

Cyclosporine

2mg/kg/day orally from Day 0 until Day 90 or a total of 13 weeks.

DRUG

cyclosporine and Daclizumab

1mg/kg plus low dose cyclosporine (2 mg/kg/day)

Trial Locations (3)

Rockefeller University Hospital, New York

Rockefeller University, New York

Rockefeller University, New York